Skip to content
Screener

Erasca, Inc. ERAS Other operating expenses

Other operating expenses at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$505.13M+90.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$115.1M+36.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$46.11M-30.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$57.99M+66.3%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$30.93M-27.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.29B+1,400%
Enterprise value$6.29B+1,462%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Research and development$27,265$25,969
In-process research and development150,000
General and administrative10,6469,661
Total operating expenses187,91135,630
Loss from operations(187,911)(35,630)
Other income (expense)
Interest income4,4494,740
Other income (expense), net22(76)

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s other operating expenses?
Erasca, Inc. (ERAS) reported other operating expenses of $187.91M in Q1 2026.
How has Erasca, Inc.'s other operating expenses changed year-over-year?
Erasca, Inc.'s other operating expenses increased by 427.4% year-over-year, from $35.63M to $187.91M.
What is the long-term trend for Erasca, Inc.'s other operating expenses?
Over 4 years (2021 to 2025), Erasca, Inc.'s other operating expenses has grown at a 3.1% compound annual growth rate (CAGR), from $124.88M to $140.91M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Erasca, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude